Lilia-Celine Lozada
Stock Analyst at JP Morgan
(1.57)
# 3,214
Out of 5,182 analysts
9
Total ratings
40%
Success rate
2.98%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lilia-Celine Lozada
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVST Envista Holdings | Maintains: Neutral | $22 → $26 | $27.84 | -6.61% | 2 | Feb 6, 2026 | |
| ATRC AtriCure | Maintains: Overweight | $42 → $48 | $29.72 | +61.51% | 4 | Dec 16, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $14 → $12 | $12.51 | -4.08% | 1 | Nov 7, 2025 | |
| TMCI Treace Medical Concepts | Downgrades: Underweight | $8 → $5 | $1.94 | +157.73% | 2 | Nov 7, 2025 |
Envista Holdings
Feb 6, 2026
Maintains: Neutral
Price Target: $22 → $26
Current: $27.84
Upside: -6.61%
AtriCure
Dec 16, 2025
Maintains: Overweight
Price Target: $42 → $48
Current: $29.72
Upside: +61.51%
DENTSPLY SIRONA
Nov 7, 2025
Maintains: Neutral
Price Target: $14 → $12
Current: $12.51
Upside: -4.08%
Treace Medical Concepts
Nov 7, 2025
Downgrades: Underweight
Price Target: $8 → $5
Current: $1.94
Upside: +157.73%